International Journal of Breast Cancer / 2018 / Article / Tab 1

Research Article

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy

Table 1

Descriptive Statistics. This table shows clinicopathologic characteristics of the study participants including demographic information, tumor characteristics, and survival data.

VariableLevelN = 84

CDK9Negative3146.3
Positive3653.7
Missing17-

ER statusNegative3239.0
Positive5061.0
Missing2-

PR statusNegative4048.8
Positive4251.2
Missing2-

Her2Neu statusNegative6377.8
Positive1822.2
Missing3-

SubtypeTriple negative2227.5
ER+/PR+/Her2Neu-3341.3
Other2531.3
Missing4-

Age at diagnosis (years)<503238.1
50+5261.9

Stage24352.4
33947.6
Missing2-

DeathNo5363.1
Yes3136.9

Locoregional recurrenceNo7892.9
Yes67.1

Distant failureNo6172.6
Yes2327.4

Recurrence (LR or Distant)No5869.0
Yes2631.0

Event (Recurrence or Death)No4958.3
Yes3541.7

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.